Tuesday, February 12, 2019

there is no unanimity

Most studies analyze the rheumatoid factor IgM, and there is no unanimity in whether patients with FRIga have a worse prognosis. When polyarthritis is analyzed with few months of evolution, the rheumatoid factor constitutes the main factor that predicts the persistence of the disease (and the opposite situation: seronegativity predicts high remission rates).

This is one of the most repeated variables in established AR and would be largely related to the delay in the introduction of antirheumatic therapy. A significant degree of impairment of functional capacity at the onset of the disease is a factor of poor prognosis and usually predicts future disability Hondrocream, although it can be reversed in part with antirheumatic therapy.

No comments:

Post a Comment